ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 124 filers reported holding ARBUTUS BIOPHARMA CORP in Q4 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $59,000 | -33.7% | 19,698 | -14.0% | 0.00% | – |
| Q4 2021 | $89,000 | +122.5% | 22,900 | +18.7% | 0.00% | – |
| Q2 2019 | $40,000 | -76.7% | 19,300 | -59.8% | 0.00% | – |
| Q1 2019 | $172,000 | -6.5% | 48,047 | 0.0% | 0.00% | – |
| Q4 2018 | $184,000 | -67.8% | 48,047 | -20.7% | 0.00% | -100.0% |
| Q3 2018 | $572,000 | -83.3% | 60,556 | -87.1% | 0.00% | -75.0% |
| Q2 2018 | $3,435,000 | -3.3% | 470,508 | -33.8% | 0.00% | -20.0% |
| Q1 2018 | $3,552,000 | -41.7% | 710,462 | -41.1% | 0.01% | -37.5% |
| Q4 2017 | $6,091,000 | -44.0% | 1,206,125 | -31.2% | 0.01% | -52.9% |
| Q3 2017 | $10,875,000 | +74.2% | 1,754,105 | +1.1% | 0.02% | +70.0% |
| Q2 2017 | $6,244,000 | +9.9% | 1,734,529 | -0.7% | 0.01% | 0.0% |
| Q1 2017 | $5,679,000 | +33.6% | 1,747,102 | +0.7% | 0.01% | +42.9% |
| Q4 2016 | $4,250,000 | -28.2% | 1,734,603 | +0.8% | 0.01% | -30.0% |
| Q3 2016 | $5,920,000 | -2.3% | 1,720,981 | -1.2% | 0.01% | -9.1% |
| Q2 2016 | $6,062,000 | -14.2% | 1,741,895 | +1.8% | 0.01% | -15.4% |
| Q1 2016 | $7,069,000 | -15.1% | 1,711,569 | -8.5% | 0.01% | +8.3% |
| Q4 2015 | $8,328,000 | -26.4% | 1,871,460 | +0.8% | 0.01% | -29.4% |
| Q3 2015 | $11,310,000 | – | 1,857,076 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Two Seas Capital LP | 825,569 | $3,211,000 | 2.46% |
| GREAT POINT PARTNERS LLC | 668,907 | $2,602,000 | 0.58% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 270,000 | $1,050,000 | 0.47% |
| QCM Cayman, Ltd. | 10,205 | $40,000 | 0.24% |
| Pitti Group Wealth Management, LLC | 50,000 | $195,000 | 0.22% |
| RTW INVESTMENTS, LP | 2,504,493 | $9,742,000 | 0.14% |
| Hudson Bay Capital Management LP | 1,805,700 | $7,024,000 | 0.07% |
| Quinn Opportunity Partners LLC | 276,485 | $1,076,000 | 0.07% |
| Kepos Capital LP | 200,000 | $778,000 | 0.06% |
| XTX Topco Ltd | 29,026 | $113,000 | 0.06% |